Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Investing Intel. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)'s share was trading at $84.71 as of April 29^th. MRK’s trailing and forward P/E were 12.31 and 9.45 respectively according to Yahoo Finance.

[caption id="attachment_1238936" align="aligncenter" width="768"] A closeup of pills in a pharmacy, representing the high quality medications of the company.[/caption]

Merck’s $3.9 billion acquisition of SpringWorks Therapeutics marks its largest deal since 2019 and...